Like many other recent IPOs, Verve Therapeutics set up in a nice technical base and is now beginning to break out. A series of lower lows shows that volume is drying up as pullbacks became shallower - a sign the stock is moving from weak hands to strong hands.
IPO intraday trading strategy idea Verve Therapeutics is genetic medicines company pioneering a new approach to the care of cardiovascular disease, or CVD, transforming treatment from chronic management to single-course gene editing medicines. The share price is rising and gonna continue this trend today. The demand for shares of the company still looks higher...